文献速递妇科

术中腹膜转移范围影响晚期卵巢癌的手术结局与生存

Peroperative extent of peritoneal metastases affects the surgical outcome and survival in advanced ovarian cancer.
PubMed 文献 · Gynecol Oncol · 2022-09-08

这项单中心观察性队列研究纳入316例接受新辅助化疗后行间歇性肿瘤细胞减灭术的III-IV期上皮性卵巢癌患者,术中记录7区域计数(7RC)以量化腹膜转移范围。多因素分析显示,7RC较高与完全或满意肿瘤细胞减灭术几率降低独立相关(OR=0.45,95%CI 0.33-0.63,p<0.001),并与较差的无进展生存期(HR=1.17,95%CI 1.08-1.26,p<0.001)和总生存期(HR=1.14,95%CI 1.04-1.25,p=0.007)独立相关。

要点

  • 术中7RC较高与完全或满意肿瘤细胞减灭术几率降低独立相关(OR=0.45)。
  • 7RC较高与较差无进展生存期独立相关(HR=1.17)。
  • 7RC较高与较差总生存期独立相关(HR=1.14)。

核心结论

  • 术中7RC表达的腹膜转移范围是完全肿瘤细胞减灭术的独立预测因素,并在肿瘤细胞减灭术完整性之外对无进展生存期和总生存期具有独立预后价值。

研究设计与样本

  • 单中心观察性队列研究,连续纳入新诊断III-IV期上皮性卵巢癌、接受新辅助化疗并行间歇性肿瘤细胞减灭术的患者,共316例纳入分析。
  • 术中探查时记录7区域计数(7RC)以系统量化腹膜转移范围,采用逻辑回归分析预测手术结局,Cox回归分析生存结局。

主要发现

  • 7RC中位数为4(四分位距2-6)。
  • 完全肿瘤细胞减灭术占58%,满意肿瘤细胞减灭术占30%,不完全肿瘤细胞减灭术占12%。
  • 多因素分析中,7RC较高与完全或满意肿瘤细胞减灭术几率降低独立相关(OR=0.45,95%CI 0.33-0.63,p<0.001)。
  • 7RC较高与较差无进展生存期独立相关(HR=1.17,95%CI 1.08-1.26,p<0.001)。
  • 7RC较高与较差总生存期独立相关(HR=1.14,95%CI 1.04-1.25,p=0.007)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Determining whether cytoreductive surgery (CRS) is feasible in patients with advanced ovarian cancer and whether extensive surgery is justified is challenging. Accurate patient selection for CRS based on pre- and peroperative parameters will be valuable. The aim of this study is to assess the association between the extent of peritoneal metastases as determined during surgery and completeness of interval CRS and survival. METHODS: This single-center observational cohort study included consecutive patients with newly diagnosed stage III-IV epithelial ovarian cancer who received neoadjuvant chemotherapy and underwent interval CRS. The 7 Region Count (7RC) was recorded during surgical exploration to systematically quantify the extent of peritoneal metastases. Logistic regression analysis was performed to predict surgical outcomes, and Cox regression analysis was done for survival outcomes. RESULTS: A total of 316 patients were included for analyses. The median 7RC was 4 (interquartile range: 2-6). Complete CRS was performed in 58%, optimal CRS in 30%, and incomplete CRS in 12% of patients. A higher 7RC was independently associated with lower odds of complete or optimal CRS in multivariable analysis (odds ratio [OR] = 0.45, 95% confidence interval [CI]: 0.33-0.63, p < 0.001). Similarly, a higher 7RC was independently associated with worse progression-free survival (hazard ratio [HR] = 1.17, 95% CI 1.08-1.26, p < 0.001) and overall survival (HR = 1.14, 95% CI 1.04-1.25, p = 0.007). CONCLUSION: The extent of peritoneal metastases, as expressed by the 7RC during surgery, is an independent predictor for completeness of CRS and has independent prognostic value for progression-free survival and overall survival in addition to completeness of CRS.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. van Stein RM, Engbersen MP, Stolk T, et al. Peroperative extent of peritoneal metastases affects the surgical outcome and survival in advanced ovarian cancer. Gynecol Oncol. 2022. PMID: 36088169. doi:10.1016/j.ygyno.2022.08.022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。